Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Lung Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 58 articles: HTML format

Single Articles

September 2020
1. LUTFI W, Martinez-Meehan D, Sultan I, Evans N 3rd, et al
   Racial disparities in local therapy for early stage non-small-cell lung cancer.
   J Surg Oncol. 2020 Sep 14. doi: 10.1002/jso.26206.
   PubMed     Abstract available
   
   
   
2. KAWAKATSU S, Mise Y, Hiratsuka M, Inoue Y, et al
   Clinical significance of subcentimeter pulmonary nodules in patients undergoing hepatectomy for colorectal liver metastases.
   J Surg Oncol. 2020;122:523-528.
   PubMed     Abstract available
   
   
   
3. COLLAUD S, Stork T, Schildhaus HU, Pottgen C, et al
   Multimodality treatment including surgery for primary pulmonary sarcoma: Size does matter.
   J Surg Oncol. 2020;122:506-514.
   PubMed     Abstract available
   
   
   
4. SUKER M, Groot Koerkamp B, Nuyttens JJ, Dwarkasing RS, et al
   The yield of chest computed tomography in patients with locally advanced pancreatic cancer.
   J Surg Oncol. 2020;122:450-456.
   PubMed     Abstract available
   
   
   August 2020
5. KORYLLOS A, Lopez-Pastorini A, Zalepugas D, Galetin T, et al
   Optimal timing of surgery for bronchial sleeve resection after neoadjuvant chemoradiotherapy.
   J Surg Oncol. 2020;122:328-335.
   PubMed     Abstract available
   
   
   
6. MINAMI K, Jimbo N, Tanaka Y, Ogawa H, et al
   Insulinoma-associated protein 1 is a prognostic biomarker in pulmonary high-grade neuroendocrine carcinoma.
   J Surg Oncol. 2020;122:243-253.
   PubMed     Abstract available
   
   
   June 2020
7. BAUMANN BC, Bernstein KA, DeLaney TF, Simone CB, et al
   Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity.
   J Surg Oncol. 2020 Jun 25. doi: 10.1002/jso.26078.
   PubMed     Abstract available
   
   
   
8. KAPETANAKIS EI, Filippiadis DK, Tomos IP, Karakatsani A, et al
   The role of percutaneous interventions in the management of lung cancer patients during the Covid-19 pandemic.
   J Surg Oncol. 2020 Jun 25. doi: 10.1002/jso.26084.
   PubMed    
   
   
   
9. LI F, Zhao Y, Yuan L, Wang S, et al
   Oncologic outcomes of segmentectomy vs lobectomy in pathologic stage IA (
   J Surg Oncol. 2020;121:1132-1139.
   PubMed     Abstract available
   
   
   
10. CHEN D, Wu X, Wen J, Xue Y, et al
    Comparison of sublobar resection and lobectomy for patients with small (
    J Surg Oncol. 2020 Jun 1. doi: 10.1002/jso.26051.
    PubMed     Abstract available
    
    
    
11. GILL RR, Barlow J, Jaklitsch MT, Schmidlin EJ, et al
    Image-guided video-assisted thoracoscopic resection (iVATS): Translation to clinical practice-real-world experience.
    J Surg Oncol. 2020;121:1225-1232.
    PubMed     Abstract available
    
    
    May 2020
12. KAPETANAKIS EI, Tomos IP, Karakatsani A, Koumarianou A, et al
    Management of surgical lung cancer patients during the COVID-19 pandemic in the financially and resource strained Greek health care system.
    J Surg Oncol. 2020 May 23. doi: 10.1002/jso.25988.
    PubMed    
    
    
    
13. XU E, David EA, Ding L, Atay SM, et al
    Sequence of biologic therapies and surgery affects survival in non-small cell lung cancer.
    J Surg Oncol. 2020 May 20. doi: 10.1002/jso.25937.
    PubMed     Abstract available
    
    
    
14. MEHTA R, Tsilimigras DI, Paredes AZ, Sahara K, et al
    Comparing textbook outcomes among patients undergoing surgery for cancer at U. S. News & World Report ranked hospitals.
    J Surg Oncol. 2020;121:927-935.
    PubMed     Abstract available
    
    
    
15. LI H, Wang Z, Yang F, Wang J, et al
    Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
    J Surg Oncol. 2020;121:1027-1035.
    PubMed     Abstract available
    
    
    April 2020
16. SHEWALE JB, Corsini EM, Correa AM, Brown EL, et al
    Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients.
    J Surg Oncol. 2020 Apr 30. doi: 10.1002/jso.25966.
    PubMed     Abstract available
    
    
    March 2020
17. SHI S, Xie H, Yin W, Zhang Y, et al
    The prognostic significance of the 8th edition AJCC TNM staging system for non-small-cell lung cancer is not applicable to lung cancer as a second primary malignancy.
    J Surg Oncol. 2020 Mar 14. doi: 10.1002/jso.25903.
    PubMed     Abstract available
    
    
    
18. CROWN A, Rocha FG, Raghu P, Lin B, et al
    Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors.
    J Surg Oncol. 2020;121:480-485.
    PubMed     Abstract available
    
    
    February 2020
19. CORSINI EM, Datar SS, Mitchell KG, Zhou N, et al
    High mutational concordance between primary colorectal tumors and associated pulmonary metastases.
    J Surg Oncol. 2020 Feb 19. doi: 10.1002/jso.25871.
    PubMed     Abstract available
    
    
    October 2019
20. SERRANO PE, Gu CS, Husien M, Jalink D, et al
    Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases.
    J Surg Oncol. 2019 Oct 14. doi: 10.1002/jso.25735.
    PubMed     Abstract available
    
    
    
21. YIN J, Zhao M, Lu T, Huang Y, et al
    Non-lung cancer specific mortality after lobectomy or sublobectomy in patients with stage IA non-small cell lung cancer </=2 cm: A propensity score analysis.
    J Surg Oncol. 2019 Oct 10. doi: 10.1002/jso.25724.
    PubMed     Abstract available
    
    
    September 2019
22. KYANG LS, Alzahrani NA, Valle SJ, Rahman MK, et al
    Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases.
    J Surg Oncol. 2019;120:794-802.
    PubMed     Abstract available
    
    
    
23. LONDERO F, Morelli A, Parise O, Grossi W, et al
    Lymphadenectomy during pulmonary metastasectomy: Impact on survival and recurrence.
    J Surg Oncol. 2019;120:768-778.
    PubMed     Abstract available
    
    
    August 2019
24. CHEN B
    Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
    J Surg Oncol. 2019 Aug 26. doi: 10.1002/jso.25687.
    PubMed    
    
    
    
25. NEVALA R, Jaamaa S, Tukiainen E, Tarkkanen M, et al
    Long-term results of surgical resection of lung metastases from soft tissue sarcoma: A single center experience.
    J Surg Oncol. 2019;120:168-175.
    PubMed     Abstract available
    
    
    July 2019
26. CORSINI EM, Mitchell KG, Mehran RJ, Rice DC, et al
    Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
    J Surg Oncol. 2019 Jul 9. doi: 10.1002/jso.25630.
    PubMed     Abstract available
    
    
    June 2019
27. STELZNER S, Radulova-Mauersberger O, Zschuppe E, Kittner T, et al
    Prognosis in patients with synchronous colorectal cancer metastases after complete resection of the primary tumor and the metastases.
    J Surg Oncol. 2019 Jun 5. doi: 10.1002/jso.25578.
    PubMed     Abstract available
    
    
    April 2019
28. PHILLIPS JD, Hasson RM
    Surgical management of colorectal lung metastases.
    J Surg Oncol. 2019;119:629-635.
    PubMed     Abstract available
    
    
    February 2019
29. LEE RM, Cardona K, Russell MC
    Historical perspective: Two decades of progress in treating metastatic colorectal cancer.
    J Surg Oncol. 2019 Feb 26. doi: 10.1002/jso.25431.
    PubMed     Abstract available
    
    
    
30. BLISS LA, Strong EA, Gamblin TC
    Surgical resectability of multisite metastatic colorectal cancer: Pushing the limits while appropriately selecting patients.
    J Surg Oncol. 2019 Feb 25. doi: 10.1002/jso.25419.
    PubMed     Abstract available
    
    
    December 2018
31. YUAN C, Tao X, Zheng D, Pan Y, et al
    The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
    J Surg Oncol. 2018 Dec 9. doi: 10.1002/jso.25308.
    PubMed     Abstract available
    
    
    
32. KADEER X, Wang L, Zhang L, Shi W, et al
    Modified hook-wire placement technique for localizing multiple pulmonary nodules.
    J Surg Oncol. 2018;118:1188-1193.
    PubMed     Abstract available
    
    
    November 2018
33. VITI A, Socci L, Congregado M, Ismail M, et al
    The everlasting issue of prolonged air leaks after lobectomy for non-small cell lung cancer: A data-driven prevention planning model in the era of minimally invasive approaches.
    J Surg Oncol. 2018 Nov 6. doi: 10.1002/jso.25289.
    PubMed     Abstract available
    
    
    October 2018
34. KUMAR NAN, Verma K, Shinde RS, Kammar P, et al
    Pulmonary metastasectomy of colorectal cancer origin: Evaluating process and outcomes.
    J Surg Oncol. 2018 Oct 17. doi: 10.1002/jso.25273.
    PubMed     Abstract available
    
    
    September 2018
35. GILL RR, Murphy DJ, Kravets S, Sholl LM, et al
    Success of genomic profiling of non-small cell lung cancer biopsies obtained by trans-thoracic percutaneous needle biopsy.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25241.
    PubMed     Abstract available
    
    
    
36. MARGONIS GA, Buettner S, Andreatos N, Wagner D, et al
    The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25251.
    PubMed     Abstract available
    
    
    
37. QUERO-VALENZUELA F, Piedra-Fernandez I, Hernandez-Escobar F
    Readmission after pulmonary resection for lung cancer.
    J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25207.
    PubMed    
    
    
    August 2018
38. NEWTON AD, Predina JD, Nie S, Low PS, et al
    Intraoperative fluorescence imaging in thoracic surgery.
    J Surg Oncol. 2018;118:344-355.
    PubMed     Abstract available
    
    
    June 2018
39. IMANISHI N, Hirai A, Yoneda K, Shimajiri S, et al
    Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung.
    J Surg Oncol. 2018;117:1563-1569.
    PubMed     Abstract available
    
    
    
40. STILES ZE, Dickson PV, Glazer ES, Murphy AJ, et al
    Desmoplastic small round cell tumor: A nationwide study of a rare sarcoma.
    J Surg Oncol. 2018;117:1759-1767.
    PubMed     Abstract available
    
    
    May 2018
41. SAMBRI A, Bianchi G, Cevolani L, Donati D, et al
    Can radical margins improve prognosis in primary and localized epithelioid sarcoma of the extremities?
    J Surg Oncol. 2018;117:1204-1210.
    PubMed     Abstract available
    
    
    April 2018
42. MIYAMOTO E, Chen-Yoshikawa TF, Ueshima C, Yoshizawa A, et al
    Transition of the programmed death 1 pathway from the primary colorectal cancer to its corresponding pulmonary metastasis.
    J Surg Oncol. 2018 Apr 17. doi: 10.1002/jso.25045.
    PubMed     Abstract available
    
    
    
43. KAAKI S, Kidane B, Srinathan S, Tan L, et al
    Is tissue still the issue? Lobectomy for suspicious lung nodules without confirmation of malignancy.
    J Surg Oncol. 2018;117:977-984.
    PubMed     Abstract available
    
    
    March 2018
44. COLLAUD S, Provost B, Besse B, Fabre D, et al
    Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?
    J Surg Oncol. 2018 Mar 24. doi: 10.1002/jso.25042.
    PubMed     Abstract available
    
    
    
45. SON BY, Cho S, Yum SW, Kim K, et al
    The maximum standardized uptake value of preoperative positron emission tomography/computed tomography in lung adenocarcinoma with a ground-glass opacity component of less than 30 mm.
    J Surg Oncol. 2018;117:451-456.
    PubMed     Abstract available
    
    
    
46. FISHER SB, Rafeeq S, Hess K, Grotz TE, et al
    Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC).
    J Surg Oncol. 2018;117:685-691.
    PubMed     Abstract available
    
    
    February 2018
47. YU WS, Lee CY, Park SY, Suh JW, et al
    Prognostic factors for resected non-small cell lung cancer in patients with type 2 diabetes mellitus.
    J Surg Oncol. 2018 Feb 6. doi: 10.1002/jso.24989.
    PubMed     Abstract available
    
    
    
48. VODICKA J, Mukensnabl P, Vejvodova S, Spidlen V, et al
    A more sensitive detection of micrometastases of NSCLC in lymph nodes using the one-step nucleic acid amplification (OSNA) method.
    J Surg Oncol. 2018;117:163-170.
    PubMed     Abstract available
    
    
    January 2018
49. QUERO-VALENZUELA F, Piedra-Fernandez I, Martinez-Ceres M, Romero-Palacios PJ, et al
    Predictors for 30-day readmission after pulmonary resection for lung cancer.
    J Surg Oncol. 2018 Jan 22. doi: 10.1002/jso.24973.
    PubMed     Abstract available
    
    
    December 2017
50. SMITHY JW, Rosen JE, Gao SJ, Kim AW, et al
    Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease.
    J Surg Oncol. 2017;116:1193-1196.
    PubMed     Abstract available
    
    
    November 2017
51. KAPETANAKIS EI, Sidiropoulou T, Koumarianou A, Kostopanagiotou K, et al
    Delivering quality lung cancer care in crisis-wracked Greece.
    J Surg Oncol. 2017 Nov 22. doi: 10.1002/jso.24874.
    PubMed    
    
    
    
52. SHE Y, Zhao L, Dai C, Ren Y, et al
    Development and validation of a nomogram to estimate the pretest probability of cancer in Chinese patients with solid solitary pulmonary nodules: A multi-institutional study.
    J Surg Oncol. 2017;116:756-762.
    PubMed     Abstract available
    
    
    October 2017
53. APRILE V, Bertoglio P, Dini P, Palmiero G, et al
    Is left upper lobectomy always worthwhile for early stage lung cancer? A comparison between left upper lobectomy, trisegmentectomy, and lingulectomy.
    J Surg Oncol. 2017 Oct 19. doi: 10.1002/jso.24884.
    PubMed     Abstract available
    
    
    September 2017
54. MARULLI G, Rendina EA, Klepetko W, Perkmann R, et al
    Surgery for T4 lung cancer invading the thoracic aorta: Do we push the limits?
    J Surg Oncol. 2017 Sep 18. doi: 10.1002/jso.24784.
    PubMed     Abstract available
    
    
    August 2017
55. WASEDA R, Klikovits T, Hoda MA, Hoetzenecker K, et al
    Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery.
    J Surg Oncol. 2017;116:227-235.
    PubMed     Abstract available
    
    
    June 2017
56. TAIOLI E, Liu B, Nicastri DG, Lieberman-Cribbin W, et al
    Personal and hospital factors associated with limited surgical resection for lung cancer, in-hospital mortality and complications in New York State.
    J Surg Oncol. 2017 Jun 1. doi: 10.1002/jso.24697.
    PubMed     Abstract available
    
    
    May 2017
57. YANG X, Sun F, Chen L, Shi M, et al
    Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registry.
    J Surg Oncol. 2017 May 22. doi: 10.1002/jso.24677.
    PubMed     Abstract available
    
    
    April 2017
58. MCINTYRE A, Ganti AK
    Lung cancer-A global perspective.
    J Surg Oncol. 2017 Apr 18. doi: 10.1002/jso.24532.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: